EN
HI
Alembic Pharmaceuticals Chart
Alembic Pharmaceuticals Share Key Metrics
Volume
98111.00
Market Cap
14514.22 CR
LTQ@LTP
11@738.40
ATP
737.19
Var Margin
16.46 %
Circuit Range
590.05-885.05
Delivery %
0 %
Value
7.23 CR
ASM/GSM
No
Market Lot
1
Summary
Alembic Pharmaceuticals share price is ₹738.4 as of 5 Jun, 2026. The stock Alembic Pharmaceuticals intraday movement has stayed between ₹727.60 and ₹745.45, while on a 52-week basis,Alembic Pharmaceuticals price 52 week high is ₹1107.90 & its 52 week low is ₹635.80.
In terms of trading activity, Alembic Pharmaceuticals has recorded a volume of 98111 shares, The Alembic Pharmaceuticals has a market cap of ₹196563124 CR. The stock’s Average Traded Price (ATP) stands at ₹737.19, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 11 @ ₹738.40.
Alembic Pharmaceuticals operates within a circuit range of ₹590.05 – ₹885.05, with a Value of ₹7.23 CR. The Delivery Percentage for the day is 0%. Additionally, Alembic Pharmaceuticals currently falls under the No framework, and trades with a market lot size of 1.
Alembic Pharmaceuticals Fundamentals
P/E Ratio
21.43
P/B Ratio
2.55
Div. Yield
1.63
Sector P/E
69.13
Sector P/B
2.98
Sec. Div. Yield
0.54
Alembic Pharmaceuticals Resistance and Support
Pivot 734.27
Resistance
First Resistance
751.14
Second Resistance
764.72
Third Resistance
781.59
Support
First Support
720.69
Second Support
703.82
Third Support
690.24
Alembic Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-05-15 | Audited Results & Final Dividend |
| 2026-02-05 | Quarterly Results |
| 2025-11-04 | Quarterly Results & Others |
| 2025-08-05 | Quarterly Results & Others |
| 2025-05-06 | Audited Results & Final Dividend |
| 2025-02-03 | Quarterly Results & Others |
Alembic Pharmaceuticals News
Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Alembic Pharmaceuticals received USFDA final approval for its Haloperidol Tablets, USP. This approval opens access to an estimated US$27 million market for the twelve months ending March 2026, strengthening the company's US generics presence.
Jun 05 2026 10:52:15
Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Alembic Pharmaceuticals received USFDA final approval for its Abbreviated New Drug Application (ANDA) for Levothyroxine Sodium Tablets USP. This drug targets an estimated market size of US$1,869 million over the next twelve months.
May 22 2026 10:59:06
Read More
Alembic Pharmaceuticals Management
| Name | Position |
|---|---|
| Chirayu Amin | Chairman & CEO |
| Pranav Amin | Managing Director |
Alembic Pharmaceuticals Similar Stocks
Natco Pharma Ltd.
893.40
-25.30 (2.75%)
Cohance Lifesciences Ltd.
431.10
5.80 (1.36%)
Jubilant Pharmova Ltd.
973.60
2.90 (0.30%)
Caplin Point Laboratories Ltd.
2033.10
13.40 (0.66%)
Dr. Agarwal's Health Care Ltd.
459.95
-5.05 (1.09%)
Rainbow Children's Medicare Ltd.
1343.30
-3.70 (0.27%)
Poly Medicure Ltd.
1419.80
14.80 (1.05%)
Vijaya Diagnostic Centre Ltd.
1372.40
13.00 (0.96%)
Concord Biotech Ltd.
1209.90
-28.30 (2.29%)
Alivus Life Sciences Ltd.
1032.50
-3.30 (0.32%)
Alembic Pharmaceuticals FAQs
The Buying Price of Alembic Pharmaceuticals share is 738.4 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Alembic Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Alembic Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Alembic Pharmaceuticals shares is 21.43. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Alembic Pharmaceuticals shares is 2.55. Useful to assess the stock's value relative to its book value.
To assess Alembic Pharmaceuticals’s valuation compare Sector P/E, P/B which are 69.13 & 2.98 with sector averages, along with growth rates and financial metrics.
The Market Cap of Alembic Pharmaceuticals is 14514.22 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Alembic Pharmaceuticals share price is 1107.90 & 635.80. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Alembic Pharmaceuticals belongs to the Healthcare sector.
Made for Traders.
Trusted by Investors.
Download FinX — trade confidently, invest
smarter, track everything.
